|Tested species reactivity||Human, Mouse, Rat|
|Published species reactivity||Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Recombinant fragment corresponding to a region within amino acids 115 and 315 of Human CTGF|
|Purification||Antigen affinity chromatography|
|Storage buffer||PBS, pH 7, with 1% BSA, 20% glycerol|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|Immunohistochemistry (Paraffin) (IHC (P))||1:100-1:1000|
|Western Blot (WB)||1:1000-1:10,000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Miscellaneous PubMed (MISC)||See 1 publications below|
PA5-32193 targets CTGF in IHC (P) and WB applications and shows reactivity with Human, mouse, and Rat samples.
The PA5-32193 immunogen is recombinant fragment corresponding to a region within amino acids 115 and 315 of Human CTGF.
The protein encoded by this gene is a mitogen that is secreted by vascular endothelial cells. The encoded protein plays a role in chondrocyte proliferation and differentiation, cell adhesion in many cell types, and is related to platelet-derived growth factor. Certain polymorphisms in this gene have been linked with a higher incidence of systemic sclerosis.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Synergistic Effect of Simvastatin Plus Radiation in Gastric Cancer and Colorectal Cancer: Implications of BIRC5 and Connective Tissue Growth Factor.
PA5-32193 was used in western blot to study the synergistic effect of simvastatin plus radiation therapy on the proliferation and survival of gastric and colorectal cancer
|Lim T,Lee I,Kim J,Kang WK||International journal of radiation oncology, biology, physics (93:316)||2015|